| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1320360 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NDUFA6 mRNA | CTD | PMID:20399798 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1320360 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NDUFA6 mRNA | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1320360 | 6480464 | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NDUFA6 mRNA] | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1320360 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NDUFA6 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1309818 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NDUFA6 mRNA | CTD | PMID:21215274 |
| 3H-1,2-dithiole-3-thione | increases expression | ISO | RGD:1309818 | 6480464 | 1,2-dithiol-3-thione results in increased expression of NDUFA6 mRNA | CTD | PMID:19162173 |
| 4,4'-diaminodiphenylmethane | affects expression | ISO | RGD:1320360 | 6480464 | 4,4'-diaminodiphenylmethane affects the expression of NDUFA6 mRNA | CTD | PMID:18648102 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1320360 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of NDUFA6 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:1320360 | 6480464 | Benzo(a)pyrene results in increased expression of NDUFA6 mRNA | CTD | PMID:15034205 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1320360 | 6480464 | AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of NDUFA6 mRNA] | CTD | PMID:15034205 |
| choline | multiple interactions | ISO | RGD:1320360 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NDUFA6 gene | CTD | PMID:20938992 |
| clofibrate | multiple interactions | ISO | RGD:1320360 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of NDUFA6 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | decreases expression | ISO | RGD:1320360 | 6480464 | Clofibrate results in decreased expression of NDUFA6 mRNA | CTD | PMID:17585979 |
| dibutyl phthalate | decreases expression | ISO | RGD:1309818 | 6480464 | Dibutyl Phthalate results in decreased expression of NDUFA6 mRNA | CTD | PMID:21266533 |
| folic acid | multiple interactions | ISO | RGD:1320360 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NDUFA6 gene | CTD | PMID:20938992 |
| hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA6 mRNA | CTD | PMID:17183730 |
| L-methionine | multiple interactions | ISO | RGD:1320360 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NDUFA6 gene | CTD | PMID:20938992 |
| paracetamol | multiple interactions | ISO | RGD:1320360 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of NDUFA6 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:1320360 | 6480464 | Acetaminophen results in increased expression of NDUFA6 protein | CTD | PMID:21329376 |
| paracetamol | affects expression | ISO | RGD:1320360 | 6480464 | Acetaminophen affects the expression of NDUFA6 mRNA | CTD | PMID:17562736 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:1320360 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of NDUFA6 mRNA | CTD | PMID:20936131 |
| resveratrol | increases expression | ISO | RGD:1320360 | 6480464 | resveratrol results in increased expression of NDUFA6 mRNA | CTD | PMID:22610192 |
| rosiglitazone | affects expression | ISO | RGD:1320360 | 6480464 | rosiglitazone affects the expression of NDUFA6 mRNA | CTD | PMID:22013433 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NDUFA6 mRNA | CTD | PMID:18191903 |
| toluene | affects expression | ISO | RGD:1309818 | 6480464 | Toluene affects the expression of NDUFA6 mRNA | CTD | PMID:21827849 |
| trans-resveratrol | increases expression | ISO | RGD:1320360 | 6480464 | resveratrol results in increased expression of NDUFA6 mRNA | CTD | PMID:22610192 |
| valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA6 mRNA | CTD | PMID:17183730 |
| zidovudine | increases expression | EXP | | 6480464 | Zidovudine results in increased expression of NDUFA6 mRNA | CTD | PMID:16894629 |